The global autoimmune disease diagnostics market is driven by improved laboratory techniques and automation.

Portland, OR -- (SBWire) -- 08/25/2017 --Autoimmune diseases refer to a body's abnormal immune response leading to production of antibodies that attack own cells and tissues, causing deterioration and destruction of healthy tissues. There are almost 80 types of autoimmune diseases prevailing worldwide including systemic lupus erythematosus or rheumatoid arthritis. According to the estimation by American Autoimmune Related Diseases Association (AARDA), autoimmune disease affects up to 50 million Americans and 75% of them are females. The tests used to diagnose the autoimmune disease include auto antibody test, antinuclear antibody test, complete blood count, C-reactive protein, and erythrocyte sedimentation rate.

Access full summary at:
https://www.alliedmarketresearch.com/autoimmune-disease-diagnostics-market

The global autoimmune disease diagnostics market is driven by improved laboratory techniques and automation, growth in public awareness for autoimmune disorders, rise in partnerships between physicians and clinical laboratories, increase in incidence of diseases such as rheumatoid arthritis and Graves and Hashimoto's Thyroid Disease. However, high frequency of false positive results and slow turnaround time for diagnostic test results restrain the market growth. Rapid technological advancements in medical field such as novel biomarkers, rise in healthcare expenditure, development of the emerging markets, and favorable government initiatives is expected to offer lucrative opportunities for the growth of the market.

The key players operating in this market are AstraZeneca, F. Hoffmann-La Roche, Novartis AG, Pfizer Inc., Sanofi-aventis, Abbott Laboratories, Beckman Coulter Inc., Inova Diagnostics Inc., Bio-Rad Laboratories Inc., and Hemagen Diagnostics Inc.

Autoimmune Disease Diagnostics Market Key Segments:

By Type
- Localized Autoimmune Disease Diagnostic
- Systemic Autoimmune Disease Diagnostic

By Product
- Drugs
- Therapeutic & Monitoring Equipment
- Diagnostic Equipment

By Technology
- Bridge Therapy
- Disease-modifying Antirheumatic Drugs (DMARD)
- Topical Therapy
- Phototherapy
- Helminthic Therapy
- Recombinant Technology

By Region
- North America
o U.S.
o Canada
o Mexico

- Europe
o Germany
o UK
o France
o Spain
o Italy
o Rest of Europe

- Asia-Pacific
o Japan
o China
o India
o Australia
o Rest of Asia-Pacific

- LAMEA
o Brazil
o Saudi Arabia
o South Africa
o South Korea
o Rest of LAMEA

Request TOC and Sample Report:
https://www.alliedmarketresearch.com/request-toc-and-sample/2698

About Allied Market Research
Allied Market Research is a Market Research Company which offers Syndicate & Custom Market Research Reports with Consulting Services.

Contact Us:
5933 NE Win Sivers Drive,
#205, Portland, OR 97220,
United States.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com